menu
    • menu

    Company profile for Onconetix

    NEW Drugs in Dev: 2
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Onconetix, a Nasdaq-listed commercial-stage biotechnology company, is dedicated to researching, developing, and commercializing innovative solutions in the field of oncology. The company's current flagship product is Entadfi®, an FDA-approved, once-daily oral therapeutic designed for treating benign prostatic hyperplasia (BPH), a prostate disorder. In addition to its existing product, Onconetix is actively expanding its portf...
    Onconetix, a Nasdaq-listed commercial-stage biotechnology company, is dedicated to researching, developing, and commercializing innovative solutions in the field of oncology. The company's current flagship product is Entadfi®, an FDA-approved, once-daily oral therapeutic designed for treating benign prostatic hyperplasia (BPH), a prostate disorder. In addition to its existing product, Onconetix is actively expanding its portfolio with a focus on therapeutics, diagnostics, and services for oncology. The company is committed to advancing solutions that benefit clinicians and patients in the oncology space.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OnconetixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cincinnati, OH 45202
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.onconetix.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onconetix Reports Two New Proteomedix Publications in Q1 2026
    Onconetix Reports Two New Proteomedix Publications in Q1 2026

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3294088/0/en/onconetix-reports-q1-2026-progress-at-proteomedix-ag-including-two-new-peer-reviewed-publications-and-initiation-of-u-s-validation-study.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Onconetix Showcases Realbotix's Vinci AI Vision System Debut
    Onconetix Showcases Realbotix's Vinci AI Vision System Debut

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270956/0/en/Onconetix-Highlights-Realbotix-s-Launch-of-Vinci-AI-Vision-System-with-Delivery-of-First-Vinci-Equipped-Humanoid-Robot-to-Ericsson.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
    Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267345/0/en/Onconetix-Highlights-Realbotix-AI-Humanoid-Robot-Delivery-Update.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Onconetix Names David White Ceo, Sammy Dorf Board Member
    Onconetix Names David White Ceo, Sammy Dorf Board Member

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265517/0/en/Onconetix-Appoints-David-White-as-Chief-Executive-Officer-and-Sammy-Dorf-as-Member-of-the-Board-of-Directors.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Onconetix Highlights Realbotix In Ericsson 6G Trial
    Onconetix Highlights Realbotix In Ericsson 6G Trial

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262465/0/en/Onconetix-Highlights-Realbotix-s-Role-in-Ericsson-s-World-First-6G-Trial-Demonstration.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Onconetix, Inc. Announces 1-For-5 Reverse Stock Split
    Onconetix, Inc. Announces 1-For-5 Reverse Stock Split

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260370/0/en/Onconetix-Inc-Announces-1-for-5-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search